Dr. Francisco Muge Almeida Matos Salgueiro, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 41 E Post Rd, White Plains, NY 10601 Phone: 914-681-0600 |
Dr. Geena Varghese, DO Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6532 Fax: 914-681-5260 |
Holly Michelle Gilbert, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 297 Knollwood Rd Ste 208, White Plains, NY 10607 Phone: 212-686-4014 Fax: 212-686-4016 |
Dr. Arthur Louis Forni, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6511 Fax: 914-682-6403 |
News Archive
A Saint Louis University School of Nursing faculty member is going to mark the first day of fall with a simple warning to senior adults: Don't let fear of falling stand in the way of being active and engaged with the world around you.
Neurologists in Boston and nationwide are objecting to a plan that would pay them less for certain diagnostic tests, a change meant to cut Medicare costs and direct more money to primary care physicians whose pay is widely seen as inadequate even before they take on more work under the national health care overhaul.
The World Food Program (WFP) on Wednesday warned that the humanitarian situation in Libya could worsen as a result of the heavy fighting and low stocks of food supplies, Reuters reports.
Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
› Verified 9 days ago